Clinical Trial Supply 2018 Report: The Quest To Shrink Wastage Levels
In meeting the growth ahead for clinical trials there must be a focus on efficiency as their supply already suffers from major issues with wastage levels. This is lack of control is problematic with the rising public scrutiny on spending by pharmaceutical companies. Forecasting and demand planning When sites are under supplied, sponsors may be forced to halt enrolment or even freeze patient treatments. This could have a large influence on the outcomes of a trial.Due to a rang...
TO READ THE FULL STORY
Please note: That all fields marked with an asterisk (*) are required.